4''-Demethylgentamicin C2
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Others |
Catalog number | BBF-00820 |
CAS | 66277-10-9 |
Molecular Weight | 449.54 |
Molecular Formula | C19H39N5O7 |
Online Inquiry
Description
4''-Demethylgentamicin C2 is a gentamicin homolog produced by Micromonospora purpurea var. nigrescens MNG-122. It has anti-gram-positive and negative bacteria activity.
Specification
Synonyms | Streptamine, O-3-deoxy-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-alpha-D-ribo-heptopyranosyl-(1-4))-2-deoxy-, D- |
IUPAC Name | 2-[4,6-diamino-3-[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-4-(methylamino)oxane-3,5-diol |
Canonical SMILES | CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)O)NC)O)N)N)N)N |
InChI | InChI=1S/C19H39N5O7/c1-7(20)12-4-3-8(21)18(29-12)30-16-9(22)5-10(23)17(15(16)27)31-19-14(26)13(24-2)11(25)6-28-19/h7-19,24-27H,3-6,20-23H2,1-2H3 |
InChI Key | JGGVZVHEMQUWFO-UHFFFAOYSA-N |
Properties
Appearance | White Powder |
Antibiotic Activity Spectrum | Gram-positive bacteria; Gram-negative bacteria; mycobacteria |
Solubility | Soluble in Water |
Reference Reading
1. C2 Screw fixation techniques in atlantoaxial instability: A technical review
Deepak Kumar Singh, Diwakar Shankar, Neha Singh, Rakesh Kumar Singh, Vipin Kumar Chand J Craniovertebr Junction Spine. 2022 Oct-Dec;13(4):368-377. doi: 10.4103/jcvjs.jcvjs_128_22. Epub 2022 Dec 7.
Atlantoaxial instability (AAI) is surgically a complex entity due to its proximity to vital neurovascular structures. C1-C2 fusion has been an established standard in its treatment for a considerable time now. Here, we have outlined the most common techniques for C2 screw fixation in practice at present such as C2 pedicle, C2 pars, C2 translaminar, C2 subfacetal, C2-C3 transfacetal, and C2 inferior facet screw. We have discussed in detail the technical as well as biomechanical aspects of each technique of C2 screw fixation in AAI and explored the intricacies of each technique.
2. T cells discriminate between groups C1 and C2 HLA-C
Malcolm J W Sim, Zachary Stotz, Jinghua Lu, Paul Brennan, Eric O Long, Peter D Sun Elife. 2022 May 19;11:e75670. doi: 10.7554/eLife.75670.
Dimorphic amino acids at positions 77 and 80 delineate HLA-C allotypes into two groups, C1 and C2, which associate with disease through interactions with C1 and C2-specific natural killer cell receptors. How the C1/C2 dimorphism affects T cell recognition is unknown. Using HLA-C allotypes that differ only by the C1/C2-defining residues, we found that KRAS-G12D neoantigen-specific T cell receptors (TCRs) discriminated between C1 and C2 presenting the same KRAS-G12D peptides. Structural and functional experiments, and immunopeptidomics analysis revealed that Ser77 in C1 and Asn77 in C2 influence amino acid preference near the peptide C-terminus (pΩ), including the pΩ-1 position, in which C1 favors small and C2 prefers large residues. This resulted in weaker TCR affinity for KRAS-G12D-bound C2-HLA-C despite conserved TCR contacts. Thus, the C1/C2 dimorphism on its own impacts peptide presentation and HLA-C-restricted T cell responses, with implications in disease, including adoptive T cell therapy targeting KRAS-G12D-induced cancers.
3. Comparative Effectiveness and Functional Outcome of C2 Dome-like Expansive Versus C2 Expansive Open-door Laminoplasty for Upper Cervical Ossification of the Posterior Longitudinal Ligament: A Retrospective Cohort Study
Chengcheng Yu, Yinan Wu, Zengjie Zhang, Ning Zhang, Xinning Yu, Fangcai Li, Weishan Chen, Qixin Chen, Wanli Li Spine (Phila Pa 1976). 2022 May 15;47(10):E448-E455. doi: 10.1097/BRS.0000000000004221. Epub 2021 Sep 14.
Study design: Retrospective Cohort Study. Objectives: This study compared the function and radiographical outcomes of the patients who underwent C2 dome-like expansive laminoplasty to those C2 expansive open-door laminoplasty for the treatment of OPLL with C2 involved. Summary of background data: There are few comparative studies of these two surgical methods. C2 dome-like and C2 expansive open-door laminoplasty are posterior approaches for posterior longitudinal ligament ossification with C2 level and above. Methods: This study performed a retrospective cohort analysis of 59 patients with OPLL up to C2 which cause compression symptoms. 31 patients underwent C2 dome-like expansive laminoplasty with C3-7 expansive open-door laminoplasty (Group Dom) and 28 underwent C2-7 expansive open-door laminoplasty (Group Exp). The preoperative and postoperative space available for cord (SAC) of C2 segment, cervical curvature index of C2-7, C2-7 range of motion, Japanese orthopedic association (JOA) score, visual analog scale (VAS) score, and neck disability index (NDI) were used to assess clinical out-comes and statistically analyzed. Results: The cervical curvature index, JOA score, and NDI significantly changed at the final follow-up in two groups with no significant intergroup differences. There were no significant differences in preoperative SAC and VAS between the two groups. At the final follow-up, the SAC of C2/3 in Group Exp was significantly larger than Group Dom, while the VAS and range of motion of Group Dom became significantly better than Group Exp. Conclusion: The C2 dome-like expansive laminoplasty can reduce postoperative neck pain more obviously and achieve better cervical curvature. C2 expansive open-door laminoplasty can get more adequate decompression in the spinal canal, which may be recommend to the patients with OPLL occupying more than 50% of the vertebral canal at C2/3, or with developmental spinal stenosis. Level of evidence: 3.
Recommended Products
BBF-00969 | Homomycin | Inquiry |
BBF-03781 | Resveratrol | Inquiry |
BBF-03774 | Cephalosporin C Zinc Salt | Inquiry |
BBF-03819 | Spinosyn A | Inquiry |
BBF-05808 | Triptolide | Inquiry |
BBF-01851 | Fumagillin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳